Albatroz Therapeutics
PrivateLast Round
Seed
Apr 25, 2023
Total Funding Raised
$3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Albatroz Therapeutics is a biotechnology company developing first-in-class antibody therapeutics to treat solid tumors and arthritic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Albatroz Therapeutics Comparables
Compare Albatroz Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Matrisome Bio | 78% | |
| Engitix Therapeutics | 76% | |
| BeOne Medicines | 59% | |
Albatroz Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 25, 2023 |
Albatroz Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Seed |
| Outram Bio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 98% MoM.
- Jan 22, 2025
Recognized on the 'leading biotech companies in Singapore 2025' list.
Albatroz Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Albatroz Therapeutics's valuation, stock price, and market status.